Immune determinants of COVID-19 disease presentation and severity
P Brodin - Nature medicine, 2021 - nature.com
Abstract COVID-19, caused by SARS-CoV-2 infection, is mild to moderate in the majority of
previously healthy individuals, but can cause life-threatening disease or persistent …
previously healthy individuals, but can cause life-threatening disease or persistent …
Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review
Background Convalescent plasma and hyperimmune immunoglobulin may reduce mortality
in patients with viral respiratory diseases, and are currently being investigated in trials as …
in patients with viral respiratory diseases, and are currently being investigated in trials as …
HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY …
Background Whether HIV infection is associated with risk of death due to COVID-19 is
unclear. We aimed to investigate this association in a large-scale population-based study in …
unclear. We aimed to investigate this association in a large-scale population-based study in …
Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient
JH Baang, C Smith, C Mirabelli… - The Journal of …, 2021 - academic.oup.com
We describe a case of chronic coronavirus disease 2019 (COVID-19) in a patient with
lymphoma and associated B-cell immunodeficiency. Viral cultures and sequence analysis …
lymphoma and associated B-cell immunodeficiency. Viral cultures and sequence analysis …
COVID-19 and cancer: current challenges and perspectives
Patients with cancer have been disproportionately affected by the COVID-19 pandemic. This
effect has included the adverse outcomes in patients with cancer who develop COVID-19 …
effect has included the adverse outcomes in patients with cancer who develop COVID-19 …
COVID-19 among US dialysis patients: risk factors and outcomes from a national dialysis provider
CM Hsu, DE Weiner, G Aweh, DC Miskulin… - American Journal of …, 2021 - Elsevier
Rationale & Objective During the coronavirus disease 2019 (COVID-19) pandemic, patients
receiving maintenance dialysis are a highly vulnerable population due to their comorbidities …
receiving maintenance dialysis are a highly vulnerable population due to their comorbidities …
[HTML][HTML] COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients
Background The clinical impact of severe coronavirus disease 2019 (COVID-19), caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in immunocompromised …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in immunocompromised …
COVID-19 and preexisting comorbidities: risks, synergies, and clinical outcomes
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated
symptoms, named coronavirus disease 2019 (COVID-19), have rapidly spread worldwide …
symptoms, named coronavirus disease 2019 (COVID-19), have rapidly spread worldwide …
Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data
Background Evidence of whether people living with HIV are at elevated risk of adverse
COVID-19 outcomes is inconclusive. We aimed to investigate this association using the …
COVID-19 outcomes is inconclusive. We aimed to investigate this association using the …
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
Suboptimal immunity to SARS-CoV-2 mRNA vaccination has frequently been observed in
individuals with various immunodeficiencies. Given the increased antibody evasion …
individuals with various immunodeficiencies. Given the increased antibody evasion …